XML 23 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Treasury Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Noncontrolling Interests [Member]
Balance at Dec. 31, 2014 $ 489,048 $ 50 $ (34,640) $ 646,595 $ (353) $ (128,095) $ 5,491
Common stock, shares outstanding at Dec. 31, 2014   50,065,382          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) attributable to Acacia Research Corporation (160,036)         (160,036)  
Payments of Dividends (25,434)     (25,434)      
Stock options exercised, shares   135,000          
Proceeds from Stock Options Exercised 938            
Stock options exercised, value 938     938      
Stock issued during period, shares, share-based compensation, net of forfeitures   450,857          
Non-cash stock compensation 11,048 $ 1   11,047      
Net (income) loss attributable to noncontrolling interests in subsidiaries 2,558           2,558
Payments to Noncontrolling Interests 4,105            
Foreign Currency Transaction Gain (Loss), Unrealized (123)       (123)    
Unrealized Gain (Loss) on Investments 261       261    
Distributions to noncontrolling interests in operating subsidiary (4,105)           (4,105)
Payments for Repurchase of Common Stock 0            
Balance at Dec. 31, 2015 314,155 $ 51 (34,640) 633,146 (215) (288,131) 3,944
Common stock, shares outstanding at Dec. 31, 2015   50,651,239          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) attributable to Acacia Research Corporation (54,067)         (54,067)  
Payments of Dividends $ 0            
Stock Repurchased During Period, Shares (13,529)            
Stock options exercised, shares   100,992          
Proceeds from Stock Options Exercised $ 326            
Stock options exercised, value       326      
Stock issued during period, shares, share-based compensation, net of forfeitures   (262,660)          
Non-cash stock compensation 9,062 $ (1)   9,063      
Net (income) loss attributable to noncontrolling interests in subsidiaries (732)           (732)
Payments to Noncontrolling Interests 1,358           (1,358)
Foreign Currency Transaction Gain (Loss), Unrealized         99    
Unrealized Gain (Loss) on Investments         40    
Distributions to noncontrolling interests in operating subsidiary             (1,358)
Payments for Repurchase of Common Stock (82)            
Balance at Dec. 31, 2016 $ 267,443 $ 50 (34,640) 642,453 (76) (342,198) 1,854
Common stock, shares outstanding at Dec. 31, 2016 50,476,042 50,476,042          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) attributable to Acacia Research Corporation $ 22,180         22,180  
Payments of Dividends $ 0            
Stock Repurchased During Period, Shares (8,669)            
Stock options exercised, shares 208,000 207,863          
Proceeds from Stock Options Exercised $ 745 $ 1   744      
Stock options exercised, value       745      
Stock issued during period, shares, share-based compensation, net of forfeitures   (35,310)          
Non-cash stock compensation 8,885 $ 0          
General and administrative expenses excluding share-based compensation       5,844      
Net (income) loss attributable to noncontrolling interests in subsidiaries (496)           (496)
Payments to Noncontrolling Interests 0            
Foreign Currency Transaction Gain (Loss), Unrealized         28    
Unrealized Gain (Loss) on Investments         (40)    
Payments for Repurchase of Common Stock (45)            
Balance at Dec. 31, 2017 $ 295,659 $ 51 $ (34,640) $ 648,996 $ (88) $ (320,018) $ 1,358
Common stock, shares outstanding at Dec. 31, 2017 50,639,926 50,639,926